Patent application number | Description | Published |
20110314079 | AGENT SYSTEM FOR REDUCING SERVER RESOURCE USAGE - A method, data processing system, and computer program product for processing information. A server-side agent running on a server data processing system monitors for a selected event for processing by the server-side agent. In response to detecting the selected event for processing by the server-side agent, the server-side agent requests information to process the selected event from a client-side agent running on a client data processing system. The server-side agent performs a subset of functions performed by the client-side agent. In response to receiving a response with the information to process the selected event from the client-side agent, the server-side agent performs a set of steps to process the selected event using the information received from the client-side agent. | 12-22-2011 |
20120210437 | Method and system to enhance accuracy of a data leak prevention (DLP) system - A Data Loss Prevention (DLP) system is enhanced according to this disclosure by augmenting the information obtained from OS API hooking with “context” information obtained from other sources, such as by monitoring an endpoint's user interface (UI). In one embodiment, the additional “context” information is obtained from one or more user interface hooks that provide the DLP system with additional information, such as the contents of one or more application windows, the UI elements contained in a particular display window, window activation or deactivation, window resizing, user input, pointer operations, and the like. This UI information defines a “context” of the application, namely, its operating state (including, without limitation, its display state), and associated user actions that define that state. When a particular OS API hook is invoked by the application, the DLP solution uses the context information to make a more accurate enforcement decision, preferably based on the UI context. | 08-16-2012 |
20130104041 | Capturing application workflow - An application workflow capture system records application usage and behavior semantically as a series of XML-based “events.” A capture tool is used to capture a target application workflow, and a replay tool is used to replay the captured data. The capture tool generates a workflow capture file that includes a set of information about a user's interaction with the application. When it is desired to analyze the application, the file is then provided to the replay tool. The replay tool consumes the workflow capture file and, based on the information therein, generates an executable. When launched by a player, the executable reads the captured workflow from the file and performs changes in the application properties and user inputs, preferably in the same order which they occur in the captured workflow. The behavior of the executable mimics that of the target application. | 04-25-2013 |
Patent application number | Description | Published |
20080220471 | Vectors and Methods Using Same - The present invention is directed to vectors and to methods of using same. | 09-11-2008 |
20100034821 | GENETIC VARIATIONS ASSOCIATED WITH TUMORS - Tumor-associated variations in protein kinases are provided. Compositions and methods for detecting such variations and for diagnosing and treating tumors are provided. | 02-11-2010 |
20100034836 | COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND ALLEVIATION OF TUMOR - The present invention is directed to methods of determining the presence of certain tumor-associated kinase polypeptides in a biological sample, and to compositions useful for the diagnosis and treatment of tumors in mammals | 02-11-2010 |
20100055095 | GENETIC VARIATIONS ASSOCIATED WITH TUMORS - Nucleotide and amino acid variations associated with tumors are provided. Methods for detecting variations and for diagnosing and treating tumors are provided. | 03-04-2010 |
20100092965 | GENETIC VARIATIONS ASSOCIATED WITH TUMORS - Nucleotide and amino acid variations associated with tumors are provided. Methods for detecting variations and for diagnosing and treating tumors are provided. | 04-15-2010 |
20100285016 | PRO34128 nucleic acids - The present invention is directed to novel polypeptides having sequence similarity to GDNFR and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention. | 11-11-2010 |
20100297615 | EGFR MUTATIONS - The present invention relates to mutations in Epidermal Growth Factor Receptor (EGFR) and methods of detecting such mutations as well as prognostic methods method for identifying a tumors that are susceptible to anticancer therapy such as chemotherapy and/or kinase inhibitor treatment. The methods involve determining the presence of a mutated EGFR gene or mutated EGFR protein in a tumor sample whereby the presence of a mutated EGFR gene or protein indicates the tumor is susceptible to treatment. | 11-25-2010 |
20110229890 | EGFR MUTATIONS - The present invention relates to mutations in Epidermal Growth Factor Receptor (EGFR) and methods of detecting such mutations as well as prognostic methods method for identifying a tumors that are susceptible to anticancer therapy such as chemotherapy and/or kinase inhibitor treatment. The methods involve determining the presence of a mutated EGFR gene or mutated EGFR protein in a tumor sample whereby the presence of a mutated EGFR gene or protein indicates the tumor is susceptible to treatment. | 09-22-2011 |
20110275072 | EGFR MUTATIONS - The present invention relates to mutations in Epidermal Growth Factor Receptor (EGFR) and methods of detecting such mutations as well as prognostic methods method for identifying a tumors that are susceptible to anticancer therapy such as chemotherapy and/or kinase inhibitor treatment. The methods involve determining the presence of a mutated EGFR gene or mutated EGFR protein in a tumor sample whereby the presence of a mutated EGFR gene or protein indicates the tumor is susceptible to treatment. | 11-10-2011 |
20130071382 | EGFR MUTATIONS - The present invention relates to mutations in Epidermal Growth Factor Receptor (EGFR) and methods of detecting such mutations as well as prognostic methods method for identifying a tumors that are susceptible to anticancer therapy such as chemotherapy and/or kinase inhibitor treatment. The methods involve determining the presence of a mutated EGFR gene or mutated EGFR protein in a tumor sample whereby the presence of a mutated EGFR gene or protein indicates the tumor is susceptible to treatment. | 03-21-2013 |
20130209473 | R-SPONDIN TRANSLOCATIONS AND METHODS USING THE SAME - Provided are therapies related to the treatment of pathological conditions, such as cancer. | 08-15-2013 |
20130324419 | METHODS FOR NUCLEIC ACID CAPTURE AND SEQUENCING - Methods of capturing and sequencing target nucleic acid molecules are provided. Methods of determining the methylation status of genomic DNA are also provided. | 12-05-2013 |
20140011821 | EGFR MUTATIONS - The present invention relates to mutations in Epidermal Growth Factor Receptor (EGFR) and methods of detecting such mutations as well as prognostic methods method for identifying a tumors that are susceptible to anticancer therapy such as chemotherapy and/or kinase inhibitor treatment. The methods involve determining the presence of a mutated EGFR gene or mutated EGFR protein in a tumor sample whereby the presence of a mutated EGFR gene or protein indicates the tumor is susceptible to treatment. | 01-09-2014 |